Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
Fig. 2 F, Sup. Fig. 2 A
Maerker M et al. (2021) |
Xla Wt + dand5 MO
NF16 (in situ hybridization) |
|
||||||
Fig. 2 D E
Maerker M et al. (2021) |
Xla Wt + dand5 MO
NF20 (in situ hybridization) |
|
||||||
Fig. 2 A middle, B
Maerker M et al. (2021) |
Xla Wt + dand5 MO
NF32 (in situ hybridization) |
|